Assembly Bio
Assembly Bio is seeking a Director of DMPK to lead drug metabolism and pharmacokinetics efforts for small molecule lead optimization and clinical development. This executive role involves supervising external DMPK scientists, guiding medicinal chemists, and ensuring comprehensive preclinical assessments while supporting regulatory filings. The position requires deep expertise in ADME, pharmacokinetic modeling, and a proven track record in pharmaceutical research and development.
Headquarters
South San Francisco, California, United States
Company Size
51-200 employees
Founded
2014
Assembly Bio is a biotechnology company focused on discovering and developing innovative antiviral therapeutics for serious viral diseases. The company leverages deep virology expertise and scientific ingenuity to pursue novel treatments that could change the paradigm for care and deliver life-changing cures. Its pipeline includes multiple programs, including two clinical-stage candidates, and Assembly Bio emphasizes ambitious, compassionate work aimed at improving patient outcomes.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Assembly Bio.
5% above the average for this role